IVD Department quantitative test for N-terminal pro Brain Natriuretic Peptide (NT-proBNP) - Vietnam Registration 240001073/PCBB-HN
Access comprehensive regulatory information for IVD Department quantitative test for N-terminal pro Brain Natriuretic Peptide (NT-proBNP) in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240001073/PCBB-HN and manufactured by Ortho-Clinical Diagnostics. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN THIẾT BỊ SISC VIỆT NAM.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
240001073/PCBB-HN
000.00.19.H26-240507-0007
Theo theo phụ lục
Theo phụ lục
Technical Details
The intended use of the IVD quantitative N-terminal pro Brain Natriuretic Peptide (NT-proBNP) test kit is as follows: (1) The quantitative N-terminal pro Brain Natriuretic Peptide (NT-proBNP) test reagent pack (VITROS Immunodiagnostic Products NT-proBNP II Reagent Pack): For in vitro diagnostic use to quantitate N-terminal pro Brain Natriuretic Peptide (NT-proBNP) in human serum and plasma (EDTA or heparin) on the VITROS ECi/ECiQ/3600 and VITROS 5600/XT 7600 Immunoassay Systems to aid in the diagnosis of heart failure and risk stratification of patients with acute coronary syndrome and heart failure. The test is also indicated to aid in the assessment of the risk of cardiovascular events and death in patients with stable coronary artery disease. The test may also be used to assess the severity of heart failure in patients diagnosed with heart failure. The test is also indicated to aid in the assessment of the risk of cardiovascular events and death in patients with stable coronary artery disease. The test may also be used to assess the severity of heart failure in patients diagnosed with heart failure. (2) The quantitative N-terminal pro Brain Natriuretic Peptide (NT-proBNP) calibrator (VITROS Immunodiagnostic Products NT-proBNP II Calibrator): For in vitro diagnostic use to calibrate the VITROS ECi/ECiQ/3600 and VITROS 5600/XT 7600 Immunoassay Systems when quantitating N-terminal pro Brain Natriuretic Peptide (NT-proBNP) in human serum and plasma (EDTA or heparin). (3) The quantitative N-terminal pro Brain Natriuretic Peptide (NT-proBNP) controls (VITROS Immunodiagnostic Products NT-proBNP II Controls): For in vitro diagnostic use to monitor the performance of the VITROS ECi/ECiQ/3600 and VITROS 5600/XT 7600 Immunoassay Systems when quantitating N-terminal pro Brain Natriuretic Peptide (NT-proBNP).
Dates and Status
May 13, 2024